Doctors Note Logo

Published on: 9/28/2026

What Is Ketorolac, and Why Is It Limited to Five Days?

Ketorolac is a potent nonsteroidal anti-inflammatory drug (NSAID) used for short-term relief of moderate to severe pain, often after surgery or injury, and it works by blocking prostaglandins rather than acting on opioid receptors. Its use is capped at five days total across all forms because prolonged exposure sharply raises the risk of stomach bleeding, ulcers, kidney injury, and cardiovascular events, and several important dosing, age, and interaction details are explained below. If pain is severe enough to need this level of medication, or if it persists past the five-day limit, the underlying cause deserves a closer look. A free, instant online symptom check can help you sort out what may be driving your pain and which type of care to seek next. It takes only a few minutes, is available anytime, and gives you clearer language to bring to your clinician.

Last reviewed for medical accuracy: 09/28/2026

answer background

Explanation

What Is Ketorolac?

Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) commonly used for short-term relief of moderate to severe pain. Unlike opioids, it does not act on opioid receptors but works by blocking enzymes (cyclooxygenase-1 and 2) involved in producing prostaglandins—chemicals that signal pain, inflammation, and fever.

Key points about ketorolac:

  • Available in oral tablets, nasal spray, and injectable form
  • Typically prescribed after surgery or for acute injuries
  • Not intended for long-term use

How Ketorolac Works

Ketorolac inhibits cyclooxygenase (COX) enzymes, reducing prostaglandin production. This leads to:

  • Lowered inflammation
  • Reduced pain signals
  • Decreased fever

Because it targets prostaglandins throughout the body, ketorolac can cause side effects in the stomach, kidneys, and cardiovascular system if used beyond recommended durations.


Common Uses

Ketorolac is prescribed for:

  • Postoperative pain (dental, orthopedic, abdominal procedures)
  • Acute musculoskeletal injuries (sprains, strains)
  • Severe migraine attacks (when other treatments are inadequate)

It is often chosen when opioid-related side effects or dependency risks are concerns. For many patients, ketorolac provides strong pain relief without sedation.


Why Is Ketorolac Limited to Five Days?

The US Food and Drug Administration (FDA) and clinical guidelines set a maximum combined duration—oral plus any other form—of five days for ketorolac. This limit is based on the balance between benefits and risks:

  1. Gastrointestinal (GI) Safety

    • Prostaglandins help protect the stomach lining.
    • Extended NSAID use increases risk of ulcers, bleeding, and perforation.
    • GI complications can be serious, especially in older adults.
  2. Kidney Function

    • Prostaglandins maintain blood flow to the kidneys.
    • Longer courses of ketorolac may lead to acute kidney injury, fluid retention, or worsening chronic kidney disease.
  3. Cardiovascular Risk

    • NSAIDs can raise blood pressure and promote fluid buildup.
    • Prolonged use is linked to heart attack or stroke, particularly in those with existing heart disease.
  4. Platelet Function and Bleeding

    • Ketorolac impairs platelet aggregation (clotting).
    • Risk of bleeding increases, especially during surgery or in patients on blood thinners.
  5. Comparative Studies

    • Clinical trials show no significant additional pain relief beyond five days.
    • Risks begin to outweigh benefits after this timeframe.

Because these risks climb with time, limiting ketorolac to five days helps ensure safe pain management while minimizing serious side effects.


Dosage and Administration

Typical dosing guidelines vary by form:

  • Injectable (IM/IV)

    • Initial dose: 30 mg every 6 hours (not to exceed 120 mg/day)
    • Renal impairment: lower dose or avoid use
  • Oral Tablets

    • 10 mg every 4–6 hours or 20 mg every 4–6 hours for the first dose
    • Maximum: 40 mg/day (for those under 65 years) or 30 mg/day (for those 65+)
  • Nasal Spray

    • 31.5 mcg per spray in each nostril, twice daily

Always follow your healthcare provider’s instructions. Do not extend therapy beyond five days without medical reassessment.


Who Should Avoid Ketorolac?

Certain individuals face higher risks and may need alternative pain relief:

  • History of peptic ulcer disease or GI bleeding
  • Chronic kidney disease or uncontrolled hypertension
  • Established cardiovascular disease (heart failure, coronary artery disease)
  • Allergic reaction to NSAIDs (hives, swelling, asthma exacerbation)
  • Concurrent use of anticoagulants (warfarin, direct oral anticoagulants)

Your doctor can help determine if ketorolac is appropriate or if another NSAID or pain reliever is safer.


Monitoring and Precautions

While on ketorolac therapy (up to five days), consider:

  • Hydration: Drink adequate fluids unless otherwise directed.
  • Blood Pressure Checks: NSAIDs can raise blood pressure—monitor regularly.
  • Kidney Function Tests: Especially in older adults or those with risk factors.
  • Signs of GI Bleeding: Watch for black or tarry stools, severe stomach pain, or vomiting blood.

If you notice any concerning symptoms, stop taking ketorolac and seek medical advice immediately.


Potential Side Effects

Most people tolerate short-term ketorolac well, but side effects can occur:

  • Common (1–10% frequency)

    • Headache, dizziness
    • Nausea, indigestion
    • Edema (swelling in hands/feet)
  • Serious (less common but critical to watch)

    • Gastrointestinal bleeding or ulcers
    • Acute kidney injury
    • Cardiovascular events (heart attack, stroke)
    • Severe allergic reactions (rash, difficulty breathing)

Report any unusual symptoms to your healthcare provider without delay.


Alternatives to Ketorolac

If ketorolac isn’t suitable, other options may include:

  • Acetaminophen for mild to moderate pain
  • Other NSAIDs (ibuprofen, naproxen) with proper dosing limits
  • Low-dose opioid combinations for short durations
  • Non-pharmacologic therapies (ice, heat, physical therapy)

Selecting the right pain relief involves balancing effectiveness against risk. Discuss options thoroughly with your doctor.


Free Symptom Check

Not sure if ketorolac is right for you, or curious about your symptoms? Consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.


Speak to a Doctor

Ketorolac can be a powerful tool for managing acute pain—but its five-day limit exists to protect your health. Always:

  • Follow your prescriber’s instructions exactly
  • Monitor for side effects and complications
  • Seek immediate care for life-threatening symptoms (severe bleeding, chest pain, difficulty breathing)

If you have any concerns or if your pain persists beyond five days, speak to a doctor for personalized advice and alternative treatment options.

(References)

  • * Sanders DY, Severance HW, Pollack CV Jr. Sickle cell vaso-occlusive pain crisis in adults: alternative strategies for management in the emergency department. South Med J. 1992 Aug;85(8):808-11. doi: 10.1097/00007611-199208000-00005. PMID: 1302470.

  • * Durante E, Dal Prà ML, Pampolini M. [I.V. ketorolac in the therapy of postoperative pain]. G Chir. 1990 Apr;11(4):243-6. PMID: 2223517.

  • * Hubbell K. Problems and pitfalls in providing acute and short-term pain relief with nonsteroidal anti-inflammatory agents. J La State Med Soc. 1996 Jan;148(1):13-8. PMID: 8576628.

  • * Fischer SP, Mantin R, Brock-Utne JG. Ketorolac and propofol anesthesia in a patient taking chronic monoamine oxidase inhibitors. J Clin Anesth. 1996 May;8(3):245-7. doi: 10.1016/0952-8180(96)00018-9. PMID: 8703462.

  • * Mattei P, Barnaby K. Rapid regression of duodenal inflammatory myofibroblastic tumor after intravenous ketorolac: case report and review of the literature. J Pediatr Surg. 2008 Jun;43(6):1196-9. doi: 10.1016/j.jpedsurg.2008.01.012. PMID: 18558206.

  • * Isiordia-Espinoza MA, Sánchez-Prieto M, Tobías-Azúa F, Reyes-García JG. Pre-emptive analgesic effectiveness of meloxicam versus tramadol after mandibular third molar surgery: a pilot study. J Oral Maxillofac Surg. 2012 Jan;70(1):31-6. doi: 10.1016/j.joms.2011.03.099. Epub 2011 Jul 23. PMID: 21783298.

  • * Akopian RV. [Comparison of epidural and opioid analgesia effects on frequency of paralytic ileus development in patients of surgical intensive care unit]. Anesteziol Reanimatol. 2013 Nov-Dec;(6):25-8. PMID: 24749260.

  • * Benyamin RM, Vallejo R, Wang V, Kumar N, Cedeño DL, Tamrazi A. Acute Epidural Hematoma Formation in Cervical Spine After Interlaminar Epidural Steroid Injection Despite Discontinuation of Clopidogrel. Reg Anesth Pain Med. 2016 May-Jun;41(3):398-401. doi: 10.1097/AAP.0000000000000397. PMID: 27035463.

  • * Cortellini G, Lippolis D, Amati S, Piovaccari G, Cortellini F, Ballardini G. Effective Ibuprofen Desensitization in a Patient with Myopericarditis. Pharmacology. 2019;103(3-4):111-113. doi: 10.1159/000495692. Epub 2018 Dec 13. PMID: 30544105.

  • * Song Q, Yang H, Yang X. Intravenous ketorolac versus metoclopramide in adult patients with migraine headaches: An updated systematic review and meta-analysis. Adv Clin Exp Med. 2024 Jul;33(7):661-667. doi: 10.17219/acem/171697. PMID: 37849443.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.